David M Cognetti

11PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modellingMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 12, 2025
Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial.

Ralph G Zinner, Eric V Mastrolonardo, Jennifer M Johnson

|Sep 11, 2025
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.

Pablo Llerena, Hani Samarah, Kathryn Nunes

|Nov 25, 2024
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.

Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena

|Mar 20, 2023
Feasibility and Cost of Telehealth Head and Neck Cancer Survivorship Care: A Systematic Review.

Emma De Ravin, Maria Armache, Frank Campbell

|Jun 06, 2022
Analysis of cost and outcomes in bony versus soft tissue midface free flap reconstruction.

Angela Alnemri, Ramez Philips, Sarah Sussman

|Oct 09, 2021
Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.

David M Cognetti, Jennifer M Johnson, Joseph M Curry

Pageof 2

Frequent Collaborators

3 joint publications

Madalina Tuluc

3 joint publications

Rita Axelrod

3 joint publications

Stacey M Gargano

3 joint publications

Pablo Llerena